The two-phase recovery framework

The next 12 weeks after a ChondroFiller hip injection follow a clear two-phase structure, and knowing that structure in advance makes each stage feel purposeful rather than simply waiting.

The first phase — Protect (weeks 1–6) — keeps loading on the hip joint deliberately limited. This is not arbitrary caution: the injectable collagen scaffold needs time to gel, bond with the joint's fibrin, and begin attracting the body's own cells into the repair site. Disrupting that process too early risks displacing the scaffold before it has stabilised.

The second phase — Strengthen (weeks 6–12) — shifts the focus towards rebuilding the hip muscles that support and protect the joint, with low-impact activities such as cycling and swimming introduced progressively.

Week 12 is a functional milestone, not the finish line. Full remodelling of the scaffold within the hip joint may take 12–24 months as the body's own tissue gradually replaces it.

Individual pace varies with cartilage grade, hip mechanics, age, and BMI. The framework here is clinical guidance; progression at each stage is confirmed at follow-up appointments with the treating clinician at Lincolnshire Hip.

Days 1–14: immediate care after the injection

Patients leave their Grantham or Sleaford appointment the same day — there is no theatre admission, no overnight stay, and no surgical wound to manage. The injection site will have a small sterile dressing, and the local anaesthetic means the hip may feel more comfortable immediately after the procedure than it will over the following 24–72 hours as that wears off.

What to expect in the first few days. Pain, soreness, swelling, and stiffness around the hip in the first two to three days is normal and expected. Paracetamol and ibuprofen taken regularly for the first two to three days help manage this; a short course of NSAIDs continued for up to seven days reduces inflammation and supports a low infection-risk environment around the joint. Keep the dressing in place and the site dry until it is reviewed.

Rest is deliberate, not optional. The collagen scaffold bonds with the joint's fibrin almost immediately on delivery, but host cells begin migrating into it over days to weeks. Protecting that early integration window matters. For the first 14 days, avoid strenuous hip loading, high-impact movement, and prolonged standing. Gentle, controlled movement within a comfortable range is preferable to complete immobility, which risks stiffness.

When to seek advice sooner. Worsening redness, increasing warmth, fever, or discharge at the injection site are not typical and warrant prompt contact with the clinical team rather than waiting for a scheduled review.

The six-week follow-up appointment — included in the pathway — is the point at which the treating clinician assesses how the scaffold is settling and clears the way for the Strengthen phase to begin.

Weeks 1–6: protecting the scaffold as it settles

The Protect phase asks for patience rather than passivity. Its purpose is mechanical: the injectable collagen scaffold needs time to adhere to the joint surface and begin drawing the hip's own progenitor cells into the matrix — a process known as acellular matrix-induced chondrogenesis. Load the hip too heavily too soon, and the scaffold may be displaced before cell migration has established it securely.

That does not mean staying on the sofa. Gentle, controlled hip mobility within a comfortable range of motion is actively encouraged throughout weeks one to six — keeping the joint moving maintains circulation and reduces stiffness without stressing the settling scaffold. Because ChondroFiller is placed into a fluid joint environment, the earliest load restrictions are likely less demanding than those following keyhole cartilage surgery, though the biological integration timeline applies equally to both routes.

What to avoid during this window: running, high-impact gym exercise, prolonged standing, and any activity placing sudden or heavy demand through the hip joint. These are not permanently ruled out — they form part of the return pathway during and beyond the Strengthen phase — but introducing them prematurely risks disrupting scaffold integration before it has anchored.

Pain levels may shift across weeks one to six. Some days the hip will feel more settled than others; this is a normal feature of the early repair process rather than a sign that something has gone wrong. Sharp escalation, or pain accompanied by heat or swelling, warrants prompt contact with the clinical team rather than waiting for the next scheduled review.

Weeks 6–12: building strength and activity

Week six marks a gear change. With the scaffold settled and the six-week review cleared, structured physiotherapy begins — not self-directed exercise, but a targeted programme led by a physiotherapist who assesses hip movement, loading capacity, and symptom response before progressing each stage.

The initial focus is on rebuilding the muscular envelope around the hip joint: gluteal strength, hip flexor control, and the short external rotators that stabilise the femoral head within the socket. A well-supported joint creates the conditions for the scaffold to continue promoting the body's own repair processes as it matures through this second phase.

Low-impact aerobic activity is typically reintroduced progressively from around week six or seven. Static cycling is usually the earliest option — it loads the hip through a controlled arc without impact. Road cycling and swimming can follow as comfort and assessment findings allow. Walking distance can extend gradually, guided by how the hip responds the day after activity rather than how it feels in the moment.

High-impact activity, twisting movements, and heavy resistance work remain on hold until beyond week twelve and until clinical clearance is given. Progress should be pain-guided throughout: a sustained increase in discomfort after a session is a signal to reduce load, not to push through it.

In published series using comparable ChondroFiller protocols, mean hip function scores have improved by approximately 30 points over 12 months — a population-level finding that reflects what a structured, phased recovery can support, not a personal guarantee for any individual patient.

What the collagen scaffold is doing inside the hip joint

The structural changes underway inside the hip joint can be tracked on MRI — and imaging data provides the clearest picture of why recovery unfolds across months rather than weeks.

Post-treatment scans in clinical studies have shown three measurable structural changes emerging progressively after ChondroFiller injection: a reduction in bone marrow oedema beneath the cartilage surface, diminished periarticular effusion within the joint space, and a visible widening of the joint gap as the scaffold occupies the worn area. None of these changes is fully established in the early weeks; all develop gradually as the collagen matrix matures and the body's own tissue consolidates within it.

The MOCART score — a validated MRI grading system that rates how completely a cartilage defect has filled and integrated — shows this maturation in measurable terms. In published clinical series, mean MOCART scores improved from 65.3 at four weeks post-treatment to 81.6 at twelve months. That progression indicates the repair tissue was still actively developing between the end of the Strengthen phase and the one-year mark. The primary published series reporting MOCART data used knee cohorts; hip-specific injection data with equivalent imaging endpoints remains more limited, and individual outcomes will vary.

The collagen scaffold itself does not remain permanently in the joint. Over approximately one to two years, it is progressively resorbed as the patient's own mature tissue consolidates in its place — a gradual biological handover. Scheduled follow-up appointments, including any imaging the clinical team recommends, are how progress along that arc is monitored in practice.

Follow-up, progress checks, and life beyond week 12

A six-week review with Professor Paul Lee is built into the pathway — a scheduled clinical check to assess scaffold integration, symptom response, and physiotherapy progression, not an optional extra.

Week 12 is a milestone, not a finishing line. Beyond it, functional loading returns in stages: occupation-specific tasks, sport-specific movement, and more demanding aerobic activity, all paced by how the hip responds rather than the calendar. If pain or function is not improving as expected by that point, bringing the review forward is the right approach — individual recovery pace varies with age, cartilage grade, hip mechanics, and body weight, and clinical sign-off is needed before each step up in activity.

For patients considering the pathway, Lincolnshire Hip is part of the MSK Doctors group and accepts patients without a GP referral, with appointments in Grantham and Sleaford.

The longer biological arc runs to one to two years, when the collagen scaffold has been fully resorbed and the hip joint's own tissue has consolidated in its place. In the Jerosch et al. prospective follow-up, the mean functional gain of 32.4 IKDC points recorded at 12 months was sustained — and slightly increased — at three-year follow-up, indicating that the structured work of recovery in the early weeks continues to support the hip long after the Strengthen phase ends.